Elsevier

Experimental Neurology

Volume 142, Issue 2, December 1996, Pages 226-243
Experimental Neurology

Regular Article
A Quantitative Spatial Analysis of the Blood–Spinal Cord Barrier: II. Permeability after Intraspinal Fetal Transplantation

https://doi.org/10.1006/exnr.1996.0194Get rights and content

Abstract

In previous experiments we utilized quantitative autoradiography to temporally describe vascular permeability of a radiolabeled vascular tracer following spinal contusion injury in the rat. In the present report we compare these findings with permeability assessments following fetal grafting in the contused rat spinal cord. At 10 days postinjury, Embryonic Day 14 spinal tissue was grafted into the lesioned spinal cord of Sprague–Dawley rats. At 7, 14, and 28 days postgrafting the α-aminoisobutyric acid (AIB) technique was used to assess blood-to-tissue transfer rates in graft and host tissue over several segments of the injured spinal cord. Regional changes in permeability were assessed using four distinct image analysis techniques. Using these methods, we have previously shown that contusion injury alone results in a chronic relapse in vascular permeability. The present data indicate that fetal transplants at 7 days postgrafting have AIB transfer rates that are significantly above uninjured control levels and are similar in magnitude to neighboring host spinal tissue. In addition, permeability in 14- and 28-day intraspinal grafts decreased relative to that of the 7-day transplant group, but remained significantly elevated at and rostral to the injury epicenter. Alternately, graft and host tissue in regions caudal to the injury epicenter (e.g., T10–L2) acquired a functional barrier to AIB as early as 14 days posttransplantation. These experiments suggest that graft development occurs in a different manner or at a different rate in segments of the injured spinal cord rostral and caudal to the injury site. Additionally, it appears that vascular permeability of the injured spinal cord can be influenced by the process of intraspinal transplantation.

References (0)

Cited by (14)

  • Exosomal miR-155 from M1-polarized macrophages promotes EndoMT and impairs mitochondrial function via activating NF-κB signaling pathway in vascular endothelial cells after traumatic spinal cord injury

    2021, Redox Biology
    Citation Excerpt :

    Spinal cord injury (SCI) is a devastating central nervous system (CNS) consequence with motor, sensory, and autonomic dysfunction. Pathophysiologically, the blood-brain barrier (BBB) or blood-spinal-cord barrier (BSCB) is ruptured after SCI, usually occurring within 5 min and lasting up to 28 days after SCI [1,2], leading to edema, inflammatory response, progressive neuron death, and glial cells activation [3]. Physiologically composed of continuous endothelial cells, pericytes, and glial cells with molecular junctions, the BSCB limits paracellular and transcellular transport in the CNS, while its dysfunction after SCI results in the infiltration of peripheral inflammatory cells and factors into the lesion and causes secondary SCI [4].

  • Systemic inflammation in traumatic spinal cord injury

    2020, Experimental Neurology
    Citation Excerpt :

    Systemic inflammation, either by endogenous or exogenous mediators, may promote intraspinal inflammation (Kigerl and Popovich, 2009; Schwab et al., 2014). Acutely after SCI, the blood-spinal cord barrier is breached and increased vascular permeability persists at 28 days post injury and also at eight weeks after injury (Herrera et al., 2010; Popovich et al., 1996; Schnell, 1999). Studies of the mechanisms underlying the chronic autoimmune disease, lupus, have shown that stress or infection can cause breaches in the blood brain barrier, allowing for high molecular weight mediators, such as antibodies, to gain access to the CNS, where they are neurotoxic and can alter neuronal function (Degiorgio et al., 2001; Faust et al., 2010; Kowal et al., 2004).

  • Proteomic analysis of the spatio-temporal based molecular kinetics of acute spinal cord injury identifies a Time-and segment-specific window for effective tissue repair

    2016, Molecular and Cellular Proteomics
    Citation Excerpt :

    The extent of microglia activation was significantly higher in gray than in white matter tracts in the caudal segments during the time period 3–7 days after injury, whereas at 10 days it dropped down. These discrepancies may be dependent on two factors: i) the metabolic changes in microglial function that are differentially affected at the gray matter necrotizing injury site and in degenerating white matter tracts, or ii) on the extent of blood-brain barrier injury, which varies between the gray and white matter (42, 47), and on the severity of injury. In this context, gray and white matters microglia express distinct morphologies and levels of cell surface antigens (48, 49), which most likely correspond with unique cell functions (50, 51).

  • Diffuse and persistent blood-spinal cord barrier disruption after contusive spinal cord injury rapidly recovers following intravenous infusion of bone marrow mesenchymal stem cells

    2015, Experimental Neurology
    Citation Excerpt :

    More recently, dynamic contrast-enhanced MRI in a rat model of SCI demonstrated a compromised BSCB as late as 56 days post-SCI (Cohen et al., 2009). Given the contribution of BSCB disruption to ongoing pathology in SCI, repair of the BSCB has been considered a target site for SCI therapies (Horner et al., 1996). It is well-established that intravenous injections of mesenchymal stem cells (MSCs) can improve functional recovery in experimental models of SCI (Osaka et al., 2010; Quertainmont et al., 2012).

  • Spinal Cord Injury and Regeneration: A Critical Evaluation of Current and Future Therapeutic Strategies

    2014, Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms
View all citing articles on Scopus
1

Present address: Laboratory of Genetics, The Salk Institute, La Jolla, CA 92186.

2

Present address: The Department of Medical Microbiology & Immunology, Ohio State University, Columbus, OH 43210.

View full text